Viewing Study NCT05126992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-01-28 @ 11:46 AM
Study NCT ID: NCT05126992
Status: COMPLETED
Last Update Posted: 2025-01-28
First Post: 2021-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: EU Secondary Data Post-Authorisation Safety Study of AZD1222
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19, Vaccine Adverse Events of Special Interest View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD1222 View
None ChAdOx1nCoV-19 View
None Vaccine Adverse Events of Special Interest View